Skip to main content

Table 19 Meta-analyses for duration of quitting (vs. current smoking) a

From: Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer

Duration of quitting

Statisticb

All lung cancerc

Squamousd

Adenoe

Number of setsf

 

58

11

11

About 3 yearsg

n

41

6

6

 

F

0.98 (0.93-1.04)

1.15 (1.03-1.28)

1.02 (0.85-1.22)

 

R

0.95 (0.84-1.08)

1.15 (1.03-1.28)

1.02 (0.85-1.22)

 

H, PH

3.55 p < 0.001

0.51, NS

0.74, NS

About 7 yearsh

n

29

4

4

 

F

0.60 (0.56-0.64)

0.74 (0.65-0.85)

0.73 (0.58-0.92)

 

R

0.57 (0.50-0.64)

0.74 (0.65-0.85)

0.73 (0.58-0.92)

 

H, PH

2.09, p < 0.001

0.09, NS

0.59, NS

About 12 yearsi

n

48

9

9

 

F

0.32 (0.30-0.34)

0.40 (0.35-0.47)

0.50 (0.41-0.60)

 

R

0.28 (0.24-0.32)

0.27 (0.18-0.40)

0.39 (0.26-0.58)

 

H, PH

4.22, p < 0.001

4.07, p < 0.001

3.68, p < 0.001

Longest vs. shortestj

n

61

12

12

 

F

0.23 (0.21-0.25)

0.19 (0.16-0.22)

0.30 (0.23-0.37)

 

R

0.24 (0.20-0.29)

0.14 (0.08-0.25)

0.21 (0.10-0.46)

 

H, PH

5.21, p < 0.001

6.68 p < 0.001

9.44, p < 0.001

  1. a Within each study, results for ex smokers are selected in the following preference order, within each sex, for:
  2. smoking product – any, cigarettes (ignoring other products), cigarettes only;
  3. cigarette type – any, manufactured (with or without handrolled), manufactured only;
  4. adjustment for other aspects of smoking – least available;
  5. comparison group – current smokers, current and recent smokers (up to 2 years);
  6. follow-up period – longest available;
  7. lung cancer type – see notes c to e;
  8. race – all or nearest available, otherwise by race;
  9. overlapping studies – principal, subsidiary;
  10. age – whole study, widest available age group;
  11. Results are then selected for:
  12. sex –- single sex results, combined sex results;
  13. adjustment for potential confounders – most available.
  14. b n = number of estimates combined, F = fixed-effect meta-analysis RR (95% CI), R = random-effects meta-analysis RR (95% CI), H = heterogeneity chisquared per degree of freedom, PH = probability value for heterogeneity expressed as p < 0.001, p < 0.05, p < 0.1 or NS (p ≥ 0.1).
  15. c All or nearest available, must include at least squamous cell carcinoma and adenocarcinoma.
  16. d Squamous cell carcinoma or nearest available, but not including adenocarcinoma.
  17. e Adenocarcinoma or nearest available, but not including squamous cell carcinoma.
  18. f Number of sets of RRs available for the key value analysis, where base for comparison is never smoked.
  19. g Category for which results are provided includes 3 years but does not include 7 years.
  20. h Category for which results are provided includes 7 years but does not include 3 or 12 years.
  21. i Category for which results are provided includes 12 years but does not include 7 years.
  22. j For this analysis only, the exposed and unexposed group have the same smoking status (i.e. ex-smokers), product and cigarette type. There is a preference (instead of that for comparison group) to select the results for the longest (=exposed) and shortest (=unexposed) duration quitters. Note that (unlike the inverse results shown in Table 18), the “shortest” quitters here may omit recent quitters, but subject to a limit of no more than two years.